SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.__)

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:
    Preliminary Proxy Statement
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material Pursuant to §240.14a-12

ARROWHEAD PHARMACEUTICALS, INC.

image_0.jpg
(Name of Registrant as Specified In Its Charter)
image_1.jpg
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
    No fee required.
    Fee paid previously with preliminary materials
    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

image_2.jpg

image_17.jpg
image_17.jpg


a0001.jpg


a0002.jpg

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Arrowhead Pharmaceuticals Charts.
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Arrowhead Pharmaceuticals Charts.